Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

plasvacc pty ltd - canine erythrocytes - unknown - canine erythrocytes blood product active 0.0 - active constituent

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - leptospirosis - dog - leptospira icterohaemorrhagiae; canine adeno virus type 2; canine coronavirus vaccine - antigen; canine distemper virus strain onderstepoort; canine parvo virus - misc. vaccines or anti sera - leptospirosis - dog - leptospira icterohaemorrhagiae vaccine active 0.0 u; canine adeno virus type 2 vaccine-viral active 0.0 u; canine coronavirus vaccine - antigen vaccine-viral active 0.0 u; canine distemper virus strain onderstepoort vaccine-viral active 0.0 u; canine parvo virus vaccine-viral active 0.0 u - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine coronavirus | canine distemper | canine parvovirus | leptospira icterohaemorrhagiae | parvovirus

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine parainfluenza type 2; gentamicin - misc. vaccines or anti sera - canine parainfluenza type 2 vaccine-viral active 0.0 tci50/do; gentamicin antibiotic other 0.0 p - immunotherapy - dog | dog - over 6 weeks old | bitch | castrate | puppy - canine parainfluenza

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

plasvacc pty ltd - canine gamma globulins; trisodium citrate - parenteral liquid/solution/suspension - canine gamma globulins vaccine active 10.0 g/l; trisodium citrate ungrouped other 4.0 g/l - immunotherapy - dog | bitch | castrate | puppy - aid in combating infection | coagulopathies | disseminated intravascular coagulation | hypoproteinaemia | pancreatitis | parvovirus enteritis | coumarin poisoning | indanedione poisoning | post-injury | post-surgery | sweet clover (dicoumarol) pois | warfarin poisoning

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - recombinant omega interferon of feline origin - parenteral liquid/solution/suspension - recombinant omega interferon of feline origin vaccine active 10.0 mu/ml - immunotherapy - cat | dog - adult | cat - queen | cat - tom | kitten - canine parvovirus | feline calicivirus | calicivirus (feline) | fcv | parvovirus

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - canine adenovirus type 2 strain manhattan - live; canine distemper virus strain onderstepoort; canine parvovirus strain 154 - live - parenteral liquid/solution/suspension - canine adenovirus type 2 strain manhattan - live vaccine-viral active 0.0 tcid50; canine distemper virus strain onderstepoort vaccine-viral active 0.0 tcid50; canine parvovirus strain 154 - live vaccine-viral active 0.0 tcid50 - immunotherapy - dog - with exclusions see label - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | infectious canine hepatitis | parvovirus

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - canine adeno virus type 2; canine distemper virus; canine parainfluenza virus; canine parvo virus - parenteral liquid/solution/suspension - canine adeno virus type 2 vaccine-viral active 0.0 tci50/do; canine distemper virus vaccine-viral active 0.0 tci50/do; canine parainfluenza virus vaccine-viral active 0.0 tci50/do; canine parvo virus vaccine-viral active 0.0 tci50/do - immunotherapy - dog - with exclusions see label - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | respiratory disease | canine adenovirus type 1 | canine adenovirus type 2 | infectious canine hepatitis | parvovirus

Saksa - saksa - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

zoetis deutschland gmbh (4402304) - canines staupevirus, u 39, lebend; canines adenovirus, typ 2, bio 13, lebend; canines parvovirus, bio 12, lebend; canine parainfluenzavirus, typ 2, bio 15, lebend - lyophilisat und lösungsmittel - canines staupevirus, u 39, lebend (35274) gewebekultur-infektiöse-dosis 50%; canines adenovirus, typ 2, bio 13, lebend (35477) gewebekultur-infektiöse-dosis 50%; canines parvovirus, bio 12, lebend (35478) gewebekultur-infektiöse-dosis 50%; canine parainfluenzavirus, typ 2, bio 15, lebend (35479) gewebekultur-infektiöse-dosis 50% - hund

Saksa - saksa - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

zoetis deutschland gmbh (4402304) - canines staupevirus, u 39, lebend; canines adenovirus, typ 2, bio 13, lebend; canines parvovirus, bio 12, lebend; canine parainfluenzavirus, typ 2, bio 15, lebend; leptospira interrogans, serotyp icterohaemorrhagiae, mslb 1008, inaktiviert; leptospira interrogans, serotyp canicola, mslb 1010, inaktiviert; leptospira kirschneri, serotyp grippotryphosa, mslb 1009, inaktiviert; tollwutvirus, stamm sad vnukovo-32, inaktiviert - lyophilisat und lösungsmittel - canines staupevirus, u 39, lebend (35274) gewebekultur-infektiöse-dosis 50%; canines adenovirus, typ 2, bio 13, lebend (35477) gewebekultur-infektiöse-dosis 50%; canines parvovirus, bio 12, lebend (35478) gewebekultur-infektiöse-dosis 50%; canine parainfluenzavirus, typ 2, bio 15, lebend (35479) gewebekultur-infektiöse-dosis 50%; teil 2 - lösungsmittel; leptospira interrogans, serotyp icterohaemorrhagiae, mslb 1008, inaktiviert (35480) keine angabe; leptospira interrogans, serotyp canicola, mslb 1010, inaktiviert (35481) keine angabe; leptospira kirschneri, serotyp grippotryphosa, mslb 1009, inaktiviert (35482) keine angabe; tollwutvirus, stamm sad vnukovo-32, inaktiviert (35200) 2 internationale einheit - hund

Euroopan unioni - hollanti - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, stam cdv bio 11/a, canine adenovirus type 2, stam cav-2 bio 13, canine parvovirus type 2b, stam cpv-2b bio 12/b, canine para-influenza type 2 virus, stam cpiv-2 bio-15 (alle levende, verzwakte), leptospira interrogans serogroep australis serovar bratislava, stam mslb 1088, l. interrogans serogroep icterohaemorrhagiae serovar icterohaemorrhagiae, stam mslb 1089, l. interrogans serogroep canicola serovar canicola, stam mslb 1090, l. kirschneri serogroep grippotyphosa serovar grippotyphosa, stam mslb 1091... - live canine distemper virus + live canine adenovirus + live canine para-influenza virus + live parvo + geïnactiveerd leptospira, immunologicals voor canidae - honden - actieve immunisatie van honden vanaf 6 weken leeftijd:voorkomen van sterfte en klinische symptomen veroorzaakt door het canine distemper virus,om te voorkomen dat de mortaliteit en de klinische verschijnselen veroorzaakt door canine adenovirus type 1,om te voorkomen dat klinische symptomen en het verminderen van virale uitscheiding veroorzaakt door canine adenovirus type 2,te voorkomen klinische tekenen, leucopoenia en virale uitscheiding veroorzaakt door canine parvovirus,om te voorkomen dat de klinische tekenen (neus en het oculair, ontladen) en het verminderen van virale uitscheiding veroorzaakt door het canine para-influenza virus,om te voorkomen dat de klinische symptomen van de infectie en urine-uitscheiding veroorzaakt door l. interrogans serogroep australis serovar bratislava,om te voorkomen dat klinische verschijnselen en de urinaire excretie en het verminderen van infecties veroorzaakt door l. interrogans serogroep canicola serovar canicola en l. interrogans serogroep icterohaemorrhagiae serovar icterohaemorrhagiae en ter voorkoming van klinische symptomen en vermindering van infectie en uitscheiding van de urine veroorzaakt door l. interrogans serogroep grippotyphosa serovar grippotyphosa.